# Physician Modified Endovascular Grafts

Study · id `cardio:ct-nct01538056` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01538056](<https://clinicaltrials.gov/study/NCT01538056>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01538056

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.

## Technical summary

Registry record NCT01538056. Allocation not applicable; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2045-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT01538056, source copy `cardio:ctgov-nct01538056-2026-01-12`, retrieved 2026-11-18)
- Start date: 2011-03 (registry gives no type) (ClinicalTrials.gov record NCT01538056, source copy `cardio:ctgov-nct01538056-2026-01-12`, retrieved 2026-11-18)
- Primary completion: 2045-01 (anticipated) (ClinicalTrials.gov record NCT01538056, source copy `cardio:ctgov-nct01538056-2026-01-12`, retrieved 2026-11-18)
- Completion: 2055-01 (anticipated) (ClinicalTrials.gov record NCT01538056, source copy `cardio:ctgov-nct01538056-2026-01-12`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT01538056, source copy `cardio:ctgov-nct01538056-2026-01-12`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01538056-2026-01-12`, retrieved 2026-11-18)

## The registry's words

- Brief title: Physician Modified Endovascular Grafts
- Acronym: PMEG
- Condition: Abdominal Aortic Aneurysms
- Intervention (Device): Fenestrated Endovascular Graft or Company Manufactured Terumo Aortic Fenestrated TREO Endovascular Graft
- Lead sponsor: University of Washington
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: University of Washington (`cardio:org-university-of-washington`)

## Provenance

Content hash: 517c880d38b32a29c26c50e5b98bc4078f849d95c9c83675f1cba8537b9a3bcc
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
